(Q42487969)

1 November 2017

title

The transgenic expression of highly inhibitory monomeric forms of phospholamban in mouse heart impairs cardiac contractility (English)

1 reference

1 November 2017

Zvaritch E

1

1 reference

1 November 2017

Backx PH

2

1 reference

1 November 2017

Jirik F

3

1 reference

1 November 2017

Kimura Y

4

1 reference

1 November 2017

de Leon S

5

1 reference

1 November 2017

Schmidt AG

6

1 reference

1 November 2017

Hoit BD

7

1 reference

1 November 2017

Lester JW

8

1 reference

1 November 2017

Kranias EG

9

1 reference

1 November 2017

MacLennan DH

10

1 reference

1 November 2017

language of work or name

English

0 references

publication date

1 May 2000

1 reference

Journal of Biological Chemistry

1 November 2017

published in

1 reference

1 November 2017

volume

275

1 reference

1 November 2017

issue

20

1 reference

1 November 2017

page(s)

14985-14991

1 reference

Intracellular calcium homeostasis

1 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1074%2FJBC.275.20.14985

Targeted ablation of the phospholamban gene is associated with markedly enhanced myocardial contractility and loss of beta-agonist stimulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.275.20.14985

Phospholamban: a prominent regulator of myocardial contractility

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.275.20.14985

Cardiac-specific overexpression of phospholamban alters calcium kinetics and resultant cardiomyocyte mechanics in transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.275.20.14985

Phospholamban inhibitory function is activated by depolymerization

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.275.20.14985

Functional Co-expression of the canine cardiac Ca2+ pump and phospholamban in Spodoptera frugiperda (Sf21) cells reveals new insights on ATPase regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.275.20.14985

Co-reconstitution of phospholamban mutants with the Ca-ATPase reveals dependence of inhibitory function on phospholamban structure

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.275.20.14985

Phospholamban domain Ib mutations influence functional interactions with the Ca2+-ATPase isoform of cardiac sarcoplasmic reticulum

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.275.20.14985

Monomeric phospholamban overexpression in transgenic mouse hearts

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.275.20.14985

Point mutations close to the AUG initiator codon affect the efficiency of translation of rat preproinsulin in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.275.20.14985

Echocardiographic assessment of left ventricular hypertrophy: comparison to necropsy findings.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.275.20.14985

Left ventricular remodelling after acute myocardial infarction--solved and unsolved issues

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.275.20.14985

Cellular basis of ventricular remodeling after myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.275.20.14985

Familial hypertrophic cardiomyopathy: a genetic model of cardiac hypertrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.275.20.14985

Chronic phospholamban-sarcoplasmic reticulum calcium ATPase interaction is the critical calcium cycling defect in dilated cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.275.20.14985

21 January 2018

Identifiers

DOI

10.1074/JBC.275.20.14985

1 reference

1 November 2017

1 reference